EurekAlert! - CancerThe premier online source for science news since 1996. A service of the American Association for the Advancement of Science.$1.8M awarded for metastatic colon cancer research- June 26, 2008 (American Association for Cancer Research) Through the generous philanthropic support of the Littlefield 2000 Trust, the American Association for Cancer Research is pleased to announce three recipients of the 2008 Jeannik M. Littlefield-AACR Grants for Metastatic Colon Cancer Research, totaling $1.8 million.http://www.eurekalert.org/pub_releases/2008-06/aafc-ma062608.php Avalon Pharmaceuticals names lead development candidate in beta-catenin inhibitor program- June 26, 2008 (Dorland Global Public Relations) Avalon Pharmaceuticals announces the nomination of AVN316 as a lead clinical development candidate in its Beta-catenin Pathway Inhibitor program. Beta-catenin is one of the most commonly activated cancer pathways and is known to play a key role in the initiation and progression of cancer, particularly colon cancer. The compound inhibits the Beta-catenin pathway and is a potent inducer of cancer cell death. Avalon plans to begin clinical testing of AVN316 in..http://www.eurekalert.org/pub_releases/2008-06/dgpr-apn062308.php ASTRO announces recipients of 2008 awards, grants- June 25, 2008 (American Society for Therapeutic Radiology and Oncology) The American Society for Therapeutic Radiology and Oncology's Research Evaluation Committee has announced the recipients of several awards and grants that are funded by the Radiation Oncology Institute (formerly the ASTRO Education and Development Fund) and distributed each year as part of the organization's overall effort to prevent, treat and cure malignancies.http://www.eurekalert.org/pub_releases/2008-06/asft-aar062508.php NCI grant launches clinical trials for colon cancer screening- June 25, 2008 (Northwestern University) A Northwestern University biomedical engineer who has developed optical technology shown to be effective for the early detection of colon cancer has received a $7.5 million grant over five years from the National Cancer Institute to further study an instrument that potentially could become a routine colon cancer screening test and to launch large-scale clinical trials. The technology could lead to the first population-wide screening test that can accurately predict the.http://www.eurekalert.org/pub_releases/2008-06/nu-ngl062508.php Major grant advances personalized therapy for brain tumors- June 25, 2008 (University of Texas M. D. Anderson Cancer Center) Researchers at The University of Texas M. D. Anderson Cancer Center will advance two new therapeutic approaches for malignant brain tumors and develop biomarkers to guide treatment decisions under a major translational research grant from the National Cancer Institute.http://www.eurekalert.org/pub_releases/2008-06/uotm-mga062508.php Different type of colon cancer vaccine reduces disease spread, Jefferson scientists show- June 24, 2008 (Thomas Jefferson University) Taking advantage of the fact that the intestines have a separate immune system from the rest of the body, scientists have found a way to immunize mice against the development of metastasis. They have shown that mice immunized with an intestinal protein developed fewer lung and liver metastases after injection with colon cancer cells than did controls. The work may portend the development of a different kind of cancer vaccine that may help prevent recurrence.http://www.eurekalert.org/pub_releases/2008-06/tju-dto062308.php Also in the June 24 JNCI- June 24, 2008 (Journal of the National Cancer Institute) Also in the June 24 issue of JNCI are a study identifying a tumor suppressor gene associated with neuroblastoma outcomes, a novel strategy for developing tumor vaccines, an analysis of a region on chromosome 8 that is associated with several common cancers, a study that shows that using NSAIDs is not associated with melanoma risk, and a commentary that proposes a strategy for evaluating large epidemiologic studies such as the Nurses' Health Study.http://www.eurekalert.org/pub_releases/2008-06/jotn-ait061908.php Blue light used to harden tooth fillings stunts tumor growth- June 24, 2008 (Medical College of Georgia) A blue curing light used to harden dental fillings also may stunt tumor growth, Medical College of Georgia researchers say.http://www.eurekalert.org/pub_releases/2008-06/mcog-blu062408.php Activation of LYN kinase is associated with imatinib-resistance in CML patients- June 24, 2008 (Journal of the National Cancer Institute) Activation of LYN kinase is associated with resistance to imatinib in patients with chronic myelogenous leukemia, researchers report in the June 24 online issue of the Journal of the National Cancer Institute.http://www.eurekalert.org/pub_releases/2008-06/jotn-aol061908.php LSUHSC inventor awarded patent for new procedure to detect cancer spread- June 24, 2008 (Louisiana State University Health Science Center) Eugene A. Woltering, M.D., F.A.C.S., professor of surgery and chief of the sections of surgical oncology and endocrine surgery at LSU Health Sciences Center New Orleans, has been awarded a US patent for a one-step method to rapidly identify "sentinel nodes;" the lymph nodes most likely to contain early metastasis from a primary cancer. Preliminary research indicates that the procedure which consists of injection of a radio-labeled dye around a..http://www.eurekalert.org/pub_releases/2008-06/lsuh-lia062408.php |